Cargando…

Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility

BACKGROUND: “Hospital-at-home” (HAH) programs have been shown to optimize resource utilization, shorten hospitalization and prevent nosocomial infection. METHODS: We retrospectively analysed data regarding implementation of an HAH unit for caring patients with hematological malignancies in our cente...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Centurión, Ignacio, Oarbeascoa, Gillen, García, María Carmen, López Fresneña, María Carmen, Martínez Carreño, María Josefa, Escudero Vilaplana, Vicente, González-Haba, Eva, Bailén, Rebeca, Dorado, Nieves, Juárez, Luis Miguel, Rodríguez Macías, Gabriela, Font López, Patricia, Encinas, Cristina, Bastos-Oreiro, Mariana, Anguita, Javier, Sanjurjo, María, Díez-Martin, José Luis, Kwon, Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457036/
https://www.ncbi.nlm.nih.gov/pubmed/34553338
http://dx.doi.org/10.1007/s12185-021-03219-2
_version_ 1784570995298795520
author Gómez-Centurión, Ignacio
Oarbeascoa, Gillen
García, María Carmen
López Fresneña, María Carmen
Martínez Carreño, María Josefa
Escudero Vilaplana, Vicente
González-Haba, Eva
Bailén, Rebeca
Dorado, Nieves
Juárez, Luis Miguel
Rodríguez Macías, Gabriela
Font López, Patricia
Encinas, Cristina
Bastos-Oreiro, Mariana
Anguita, Javier
Sanjurjo, María
Díez-Martin, José Luis
Kwon, Mi
author_facet Gómez-Centurión, Ignacio
Oarbeascoa, Gillen
García, María Carmen
López Fresneña, María Carmen
Martínez Carreño, María Josefa
Escudero Vilaplana, Vicente
González-Haba, Eva
Bailén, Rebeca
Dorado, Nieves
Juárez, Luis Miguel
Rodríguez Macías, Gabriela
Font López, Patricia
Encinas, Cristina
Bastos-Oreiro, Mariana
Anguita, Javier
Sanjurjo, María
Díez-Martin, José Luis
Kwon, Mi
author_sort Gómez-Centurión, Ignacio
collection PubMed
description BACKGROUND: “Hospital-at-home” (HAH) programs have been shown to optimize resource utilization, shorten hospitalization and prevent nosocomial infection. METHODS: We retrospectively analysed data regarding implementation of an HAH unit for caring patients with hematological malignancies in our center, during the COVID-19 pandemic. RESULTS: Between January and November 2020, 105 patients were treated in the HAH unit for a total of 204 episodes. Nine patients with multiple myeloma (MM) received autologous HSCT (auto-HSCT). Three patients with acute myeloid leukemia (AML) received consolidation therapy, 32 patients underwent clinical and analytical monitoring, 20 were transplant recipients early discharged (5 auto-HSCT and 15 allo-HSCT) and 2 had received CART cells therapy. Azacitidine, bortezomib and carfilzomib were administered at home to 54 patients with AML, myelodysplastic syndrome (MDS) or MM. A median of 17 (IQR 13–19) days of admission per patient and a total of 239 visits to the Hematology day-care hospital were avoided. Overall, 28 patients (14% of all episodes) needed admission to the hospital, 4 of them due to COVID-19. CONCLUSIONS: Implementation of a Hematology HAH unit was feasible and safe, and provided thorough advanced care to a high-risk population. Advanced care-at-home strategies can be crucial during times of COVID-19 to minimize treatment interruptions and reduce the risk of cross-infections.
format Online
Article
Text
id pubmed-8457036
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-84570362021-09-23 Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility Gómez-Centurión, Ignacio Oarbeascoa, Gillen García, María Carmen López Fresneña, María Carmen Martínez Carreño, María Josefa Escudero Vilaplana, Vicente González-Haba, Eva Bailén, Rebeca Dorado, Nieves Juárez, Luis Miguel Rodríguez Macías, Gabriela Font López, Patricia Encinas, Cristina Bastos-Oreiro, Mariana Anguita, Javier Sanjurjo, María Díez-Martin, José Luis Kwon, Mi Int J Hematol Original Article BACKGROUND: “Hospital-at-home” (HAH) programs have been shown to optimize resource utilization, shorten hospitalization and prevent nosocomial infection. METHODS: We retrospectively analysed data regarding implementation of an HAH unit for caring patients with hematological malignancies in our center, during the COVID-19 pandemic. RESULTS: Between January and November 2020, 105 patients were treated in the HAH unit for a total of 204 episodes. Nine patients with multiple myeloma (MM) received autologous HSCT (auto-HSCT). Three patients with acute myeloid leukemia (AML) received consolidation therapy, 32 patients underwent clinical and analytical monitoring, 20 were transplant recipients early discharged (5 auto-HSCT and 15 allo-HSCT) and 2 had received CART cells therapy. Azacitidine, bortezomib and carfilzomib were administered at home to 54 patients with AML, myelodysplastic syndrome (MDS) or MM. A median of 17 (IQR 13–19) days of admission per patient and a total of 239 visits to the Hematology day-care hospital were avoided. Overall, 28 patients (14% of all episodes) needed admission to the hospital, 4 of them due to COVID-19. CONCLUSIONS: Implementation of a Hematology HAH unit was feasible and safe, and provided thorough advanced care to a high-risk population. Advanced care-at-home strategies can be crucial during times of COVID-19 to minimize treatment interruptions and reduce the risk of cross-infections. Springer Singapore 2021-09-22 2022 /pmc/articles/PMC8457036/ /pubmed/34553338 http://dx.doi.org/10.1007/s12185-021-03219-2 Text en © Japanese Society of Hematology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Gómez-Centurión, Ignacio
Oarbeascoa, Gillen
García, María Carmen
López Fresneña, María Carmen
Martínez Carreño, María Josefa
Escudero Vilaplana, Vicente
González-Haba, Eva
Bailén, Rebeca
Dorado, Nieves
Juárez, Luis Miguel
Rodríguez Macías, Gabriela
Font López, Patricia
Encinas, Cristina
Bastos-Oreiro, Mariana
Anguita, Javier
Sanjurjo, María
Díez-Martin, José Luis
Kwon, Mi
Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility
title Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility
title_full Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility
title_fullStr Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility
title_full_unstemmed Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility
title_short Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility
title_sort implementation of a hospital-at-home (hah) unit for hematological patients during the covid-19 pandemic: safety and feasibility
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457036/
https://www.ncbi.nlm.nih.gov/pubmed/34553338
http://dx.doi.org/10.1007/s12185-021-03219-2
work_keys_str_mv AT gomezcenturionignacio implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT oarbeascoagillen implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT garciamariacarmen implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT lopezfresnenamariacarmen implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT martinezcarrenomariajosefa implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT escuderovilaplanavicente implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT gonzalezhabaeva implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT bailenrebeca implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT doradonieves implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT juarezluismiguel implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT rodriguezmaciasgabriela implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT fontlopezpatricia implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT encinascristina implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT bastosoreiromariana implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT anguitajavier implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT sanjurjomaria implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT diezmartinjoseluis implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility
AT kwonmi implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility